Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug manufacturing
Payers
CMS names participants in Cell and Gene Therapy Access Model
As expected, there will be 35 voluntary participants in the CMS' new Cell and Gene Therapy Access Model.
Noah Tong
Jul 15, 2025 5:26pm
Aetna sues drugmakers for widespread price-fixing and collusion
Jan 3, 2025 4:50pm
Hims & Hers adds GLP-1 injections to its weight loss program
May 20, 2024 9:00am
Mark Cuban Cost Plus Drugs to start manufacturing it own meds
Mar 4, 2024 6:00pm
CDC seeks new weapons against antimicrobial resistance
Apr 12, 2023 5:05pm
